Early stage IT and Healthcare Investing

Corixa

portfoliocompanies

company snapshot

Corixa

Corixa was formed in 1994 to develop vaccines and therapeutic products for cancer and infectious diseases based on novel approaches to immunization, stimulation, and culture of cytotoxic T cells and T helper cells. Corixa had an initial public offering in 1997, then was acquired by GlaxoSmithKline in 2005.

website
www.gsk.com
Leadership
Follow The Company
Investment Team
Facebook Google+ Twitter Email LinkedIn Share